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Perinatalhypoxic-ischemicencephalopathy(HIE)isanimportantcauseofbraininjuryinthenewbornandcanresultinlong-term
devastatingconsequences. Perinatalhypoxia is a vital cause of long-term neurologic complications varying from mild behavioural
deﬁcits to severe seizure, mental retardation, and/or cerebral palsy in the newborn. In the mammalian developing brain, ongoing
research into pathophysiological mechanism of neuronal injury and therapeutic strategy after perinatal hypoxia is still limited.
With the advent of promising therapy of hypothermia in HIE, this paper reviews the pathophysiology of HIE and the future
potential neuroprotective strategies for clinical potential for hypoxia suﬀerers.
1.Introduction
Perinatal hypoxic-ischemic encephalopathy (HIE) occurs
in one to three per 1000 live full-term births [1]. Of
aﬀected newborns, 15%–20% of aﬀected newborns will
die in the postnatal period, and an additional 25% will
develop severe and permanent neuropsychological sequelae,
including mental retardation, visual motor or visual per-
ceptive dysfunction, increased hyperactivity, cerebral palsy,
and epilepsy [2] .T h eo u t c o m e so fH I Ea r ed e v a s t a t -
ing and permanent, making it a major burden for the
patient, the family, and society. It is critical to identify
and develop therapeutic strategies to reduce brain injury
in newborns with HIE. The underlying pathophysiology
of perinatal HIE is diﬃcult to study in the human,
thus the neonatal rat model for HI brain injury has
been developed to model this human condition. Much
of what we know is derived from studies conducted in
animal models. Rodents were the most frequently used
animals in HIE research, followed by piglets and sheep
[3].
2.Gestationaland ChronologicalAge
The neuropathological features of perinatal HIE vary con-
siderably with the gestational age of the infant, the nature of
the insult, and the intervention types. Studies of the eﬀect of
hypoxemia on brain energy metabolism in the immature rat
brain have delineated a particular window of vulnerability,
characterized by greater vulnerability in the second postnatal
week,comparabletothehumanbrainattermthanintheﬁrst
p o s t n a t a lw e e k ,c o m p a r a b l et ot h eh u m a np r e m a t u r eb r a i n .
In addition, based on the evidence of more resistance of
cerebral energy metabolisms and longer duration of survival
in the immature than in the adult brains submitted to
asphyxia insults, there is a long-held general notion that the
perinatal brain is more tolerant to asphyxia than the adult
brain [4, 5]. However, neuropathological studies indicate
that many critical neuronal groups are more vulnerable to
HI injury in the immature animals, particularly related to
enhanced density and function of excitatory amino acid
receptors and enhanced vulnerability to attack by reactive
oxygen species (ROS) and reactive nitrogen species (RNS)
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2.1. Major Neuropathology. The developmentof brain injury
after HI insult is an evolving process imitated during the
acute insult and extending into a reperfusion phase. The
principle pathogenetic mechanism underlying neurological
damage in HIE resulting from hypoxemia/ischemia or both
is deprivation of glucose and oxygen supply which causes a
primary energy failure and initiates a cascade of biochemical
eventsleading to cell dysfunction and ultimately to cell death
[6, 7].A consequentreperfusion injury oftendeterioratesthe
brain metabolism by increasing the oxidative stress damage.
Particular roles for increase in extracellular glutamate,
excessive activation of glutamate receptors (excitotoxicity),
increase in cytosolic calcium (Ca2+), and generation of free
radicals are emphasized.
The temporal aspects of the changes in glucose and
energy metabolism after HI insult have been identiﬁed and
include primary energy failure and secondary energy failure
[8–13]. Immediately after HI insults, primary energy failure,
depletion of oxygen precludes oxidative phosphorylation
(decrease in high-energy phosphorylated compounds such
as ATP and phosphocreatine) and results in a switch to
anaerobic metabolism, causing accumulation of lactate and
the associated H+. The accumulation of lactate and the
associated H+ initially is beneﬁcial for adoption to oxygen
deprivation, but later, with progression of lactate formation,
it has deleterious eﬀects on (1) impairment of vascular
autoregulation, a potential for advanced ischemic injury, (2)
inhibition of phosphofructokinase activity by low pH, and
(3) a biochemical cascade leading to cellular injury [8]. The
occurrence of secondary energy failure varies according to
species and nature of the insult with onset at appropriately
8∼16 hours and a nadir at 24∼48 hours. High-energy
phosphate levels recovered to baseline levels in 2∼3h o u r s
after reperfusion and reoxygenation, and a second decline in
high-energy phosphate was pronounced at the next 48 hours
[9, 11, 12].
An initial decrease in high-energy phosphate triggers a
series of additional mechanisms, beginning with a failure of
the ATP-dependent Na+-K+ pump. Transcellular ion pump
failure results in the intracellular accumulationof Na+,C a 2+,
and water (cytotoxic edema) followed by membrane depo-
larization, excessive release of excitatory neurotransmitters,
speciﬁcally glutamate, increase of cytosolic Ca2+,a c t i v a t i o n
of phospholipase, and generation of free radicals. During
the past 2 decades, remarkable studies have demonstrated
the critical role for glutamate as the mediators of neuronal
deathintheHIinsult[14–16].Glutamateisthepredominant
excitatory amino acid neurotransmitter in the brain and has
3 major types of ionotropic receptors, NMDA, AMPA, and
KA, as well as a group of G-protein-linked metabotropic
glutamatereceptor,existinginmostneuronsandgliapossess.
Normally, glutamate ionotropic receptors work coopera-
tively in stabilization of synapses and display a sequential
participation in activity-dependent neuronal plasticity and
neuronal excitation for normal tasks such as learning and
memory. However, their vital role and enhanced function
in the perinatal period also make neurons more vulnera-
ble to excitotoxicity. Extracellular glutamate concentrations
increase manifold with HI insults [17–19], and speciﬁc
glutamate receptor channel blockers ameliorate brain injury
in HIE [20]. The ontogeny of glutamate, transient dense
expression of NMDA receptors and GluR2-deﬁcient AMPA
receptors, is relevant to the vulnerability of immature brain
regionstoexcitotoxiccelldeathinHIE[21,22].Thepresence
of a GluR2 subunit renders the AMPA receptors imperme-
able to calcium. The approximate time of peak sensitivity
of excitotoxicity in rats is 6 days for NMDA and 9∼10 days
for AMPA, appropriate to human prematurity and term
newborn, respectively [23, 24]. Moreover, the topography of
glutamate synapses, early expression of glutamate receptors
in human hippocampus, cerebral cortex, and deep nuclear
structures, is similar to regions vulnerable to HI injury in the
newborn [18, 19, 25] .T h ei n c r e a s ei ne x t r a c e l l u l a rg l u t a m a t e
concentration and activation of glutamate receptors after
hypoxia-ischemia triggers excitotoxic cascade. There is an
increase in cytosolic Ca2+ by inﬂux through open NMDA
and calcium permeable AMPA receptor channels and other
voltage-dependent Ca2+ channels, and the release of calcium
from intracellular stores. The deleterious eﬀects of increased
cytosolic calcium include the activation of neuronal nitric
oxide synthase (nNOS) to form nitric oxide, generation of
free radicals, and degradation of cellular lipids by activation
of phospholipases, of cellular proteins by activation of
protease, and of cellular DNA by activation of nucleases,
as well as accentuation of mitochondrial injuries [26–28].
Mitochondrial outer membrane permeabilization, in turn,
elicits mitochondrial release of cytochrome C, activation
cleavage of caspases 9 and 3, and apoptosis-inducing factor
(AIF), leading to apoptosis [29]. The combined eﬀects of
cellular energy failure, acidosis, glutamate release, intracellu-
lar Ca2+ accumulation, lipid peroxidation, and nitric oxide
neurotoxicity serve to disrupt essential components of the
cell with its ultimate death. The mechanism of neuronal cell
death after hypoxia-ischemia includes neuronal necrosis and
apoptosis, depending principally on the severity of the insult
andthematurationalstateofthecell.Thereisacontinuumof
necrosis and apoptosis, and often the early cell death appears
necroticandlatercelldeathappearsapoptotic[30,31].Initial
decreaseinhigh-energyphosphateswill resultinimpairment
of ATP-dependent Na+-K+ pump, which in the severe
insult causes an acute inﬂux of Na+,C l −,a n dw a t e rw i t h
consequent cell swelling, cell lysis, and thus early cell death
by necrosis whereas in less severe insult causes membrane
depolarization followed by a cascade of excitotoxicity and
oxidative stress leading to a delayed cell death, principally
apoptosis. Apoptosis is more prevalent as a mode of death
in the perinatal brain, and both caspase-dependent and
caspase-independent mechanisms of apoptotic cell death
have been recognized (Figure 1).
Experimental studies indicate that the ﬁrst observable
change in the neuron is cytoplasmic vacuolation, caused by
mitochondrial swelling, occurringwithin 5∼30minutesafter
the onset of hypoxia, and the diﬀerentiating oligodendro-
cytes exhibit approximately the same sensitivity to glucose
and oxygen deprivation as do neurons. In the immature
and mature brain, the order of cellular elements vulner-
able to hypoxia-ischemia is neuron > oligodendroglia >
astrocyte > microglia [32]. Yue et al. demonstrated thatJournal of Biomedicine and Biotechnology 3
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Figure 1: Proposed pathogenesis of hypoxic-ischemic encephalopathy. The central roles for ATP depletion, membrane depolarization,
glutamate-mediated excitotoxicty, and voltage-dependent and glutamate-activated Ca2+ channels are apparent. An initial decrease in high-
energy phosphates can result in an acute inﬂux of Na+,C l −, and water with consequent cell death (necrosis) in the severe insult, whereas
in less severe insult, it causes membrane depolarization followed by a cascade of excitotoxicity and oxidative stress leading to a delayed
cell death, principally apoptosis. Persistent membrane depolarization results excessive presynaptic glutamate release, reversal of glutamate
transport in glia and neural terminals, and activation of NMDA and immature (GluR2 deﬁciency) AMPA receptors with profound Ca2+
inﬂux with a series of Ca2+-mediated cascades to cell death. The deleterious eﬀects of cytosolic Ca2+ are multiple, including degradation of
cellular lipids by activation of phospholipase and of cellular DNA by activation of nucleases and enhancement of generation of free radicals
and nitric oxide (NO) by increase of nitric oxide synthase (NOS) [7, 8, 26]. AMPA: α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate;
ER:endoplasmicreticulum; mGlu:metabotropic glutamate;NMDA:N-methyl-D-aspartic acid; NOS: nitricoxidesynthase;VDCC: voltage-
dependent calcium channels.
apoptotic neuronal death predominated among immature
neurons, whereas necrotic cell death predominated among
mature neurons [33]. The feature of neuropathology varies
according to the developing age as hypoxia-ischemia insult.
Three major regional patterns of selective neuronal necrosis
in newborns with HIE, especially the term newborns, diﬀuse
disease, cerebral-deep nuclear with prominent involvement
of cerebral neocortex, hippocampus, and basal ganglia-
thalamus, and deep nuclear-brain stem disease [34, 35].
The principal form of hypoxia-ischemic brain injury in
the immature brain involves cerebral white matter, causing
periventricular leukomalacia (PVL), and the data indicate an
implication of a particular maturation-dependent intrinsic
vulnerability of premyelinating oligodendrocytes (pre-OLs)
to both endogenous and exogenous reactive oxygen species
[35–37]. The immature brain has a propensity for ischemia
to cerebral white matter because of the presence of (1)
vascular end zones and border zones in that region and (2)
impairment ofcerebrovascular autoregulation[7]. Nessetal.
noted a transition of cell death in white matter from early
necrotic deaths to hybrid cell deaths to classical apoptosis
between 4 and 24h of recovery from hypoxia-ischemia [38].
The delayed time course of apoptosis in pre-OLs supports
the feasibility of interventions to improve clinical outcomes
for newborns surviving birth asphyxia.
3.PotentialTherapiesforNeonatal
Hypoxic-Ischemic Encephalopathy
3.1. Supportive Intensive Care. Perinatal HIE is a major
cause of death and disability worldwide which has been
limited to supportive intensive care. It includes correction
ofhemodynamic andpulmonary disturbances(hypotension,
metabolic acidosis, and maintenance of adequate venti-
lation), correction of metabolic disturbances of glucose,
calcium, magnesium, and electrolytes, treatment of seizures
if present, and monitoring for other organ system dysfunc-
tions, such as acute renal failure. Maintenance of adequate
ventilation and adequate perfusion is a central aspect of
supportive care. Oxygendeprivationmay lead to disturbance
of cerebrovascular autoregulation with consequence of a
pressure-passive cerebral circulation and increase additional
neuronal and white matter injury. Severe hyperoxia in the
ﬁrst hours of life may contribute to increased oxidative
stress, deleterious to long-term neurological consequences
[39, 40], and the guideline of the 2010 International Con-
sensus on Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care Science with Treatment Recommenda-
tions (CoSTR) in the International Liaison Committee on
Resuscitation (ILCOR) recom m e n d st h a t ,f o rt e r mb a b i e s ,
it is better to begin resuscitation with room air rather than4 Journal of Biomedicine and Biotechnology
100% oxygen[41]. In addition, the maintenance of adequate
perfusion to brain, more related to adequate arterial blood
pressure than intracranial pres s u r e ,i si m p o r t a n tf o rp r e v e n -
tion of additional ischemic injury.
3.2. Control of Seizures. The presence of seizure, practically
occurring within the ﬁrst hours, predicates a poor outcome
of HIE. Therefore, antiepileptic drugs (AEDs) are among
the medications most commonly used in perinatal HIE. The
energy metabolism can be compromised by the hyperactive
neurons, and both acute energy deprivation after HI insult
and seizures are implicated in excitotoxicity. Thus, the
therapeutic value of AEDs may include not only control
of seizure activity but also potentially the beneﬁt for the
compromised cellular energy metabolism. Studies about
perinatal HIE showed a beneﬁcial eﬀectofpretreatment with
barbiturates [42, 43]. Phenobarbital remains the preferred
drugforthetreatmentofseizuresinneonateswithHIE[7].It
is still a controversial issue whether phenobarbital treatment
should be administered before the seizure attacks. Close
observation with use of continuous EEG to identify seizures
is optimal for management of the asphyxiated infants.
3.3. Neuroprotective Strategies. At present, no individual
neuroprotective agents have been proven safe and eﬀective
for the protection of neonates from neurological sequels
after HI insults. The insight into the biochemical and
cellular mechanisms of neuronal injury with perinatal HIE
helps to provide interventions to interrupt those deleterious
cascades, principally focusing on the potential eﬀects of
free radical scavengers, such as N-acetylcysteine (NAC)
and allopurinol, magnesium, glutamate receptor blockers,
erythropoietin (Epo), and hypothermia. NAC is a free
radical scavenger and has been demonstrated to minimize
hypoxia-ischemia-induced brain injury in various acute
models [44–46]. Combination therapy of NAC and systemic
hypothermia improves infarct volume, myelin expression
after focal HI injury [44]. Treatment of allopurinol, a
xanthine oxidase inhibitor and free radical scavenger, also
exerts beneﬁt on reduction of cerebral edema and neu-
ropathological damage after neonatal HIE [47]. Epo, the
major haemopoietic growth factor, is now considered to
have beneﬁcial eﬀects in various nervous system disorders
based on the eﬀects of prevention of metabolic compromise,
neuronal and vascular degeneration, and inﬂammatory
cell activation [48–50]. Gonzalez et al. demonstrated that
the treatment of Epo preserves hemispheric brain vol-
ume after an occlusive cerebral injury in P10 rats [48].
Other experimental studies concerning the potential value
of magnesium sulfate reveal that blockers of glutamate
receptors have conﬂicting results. However, the most potent
and promising intervention to prevent energy depletion
is hypothermia. Experimentally, reducing body tempera-
ture to 3∼5◦C below the normal level reduces cerebral
injuries, including a decrease in brain energy utilization,
reduction of infarct size, and amelioration of neuronal cell
loss and hippocampal structure, and improves neurological
outcomes after asphyxia [51–54]. The beneﬁcial eﬀects of
mild hypothermia occur at multiple sites in the cascade
to cell death. Hypothermia must be commenced before
the onset of delayed energy failure and particularly exci-
tatory features, such as seizures [7]. Early induction of
hypothermia in human infants who had perinatal HIE
improves survival and reduces the rate of disability of those
survivors [41, 55–58]. The guideline of ILCOR CoSTR 2010
recommends therapeutic hypothermia as a standard practice
for term to near term infants with moderate to severe HIE
[41].
4.Conclusion
Hypoxia-ischemia in the perinatal period is a major cause of
neonatal death and long-term disability. There are advances
in research of cellular processes and molecular mechanisms
underlying HIE over the last 2 decades. Hypothermia is the
only treatment eﬀective in neonatal HIE at present. Com-
bined therapy of hypothermia and other neuroprotective
strategies, focusing on prevention of acute injuries, increase
of therapeutic time window, and enhancement of neural
repair, is expected to improve the neurological outcomes of
HIE.
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